Skip to main content
. 2024 Sep 17;19(9):e0310170. doi: 10.1371/journal.pone.0310170

Fig 3. Saliva concentration of free testosterone after 0–12 weeks of TrigozimR supplementation (0–1800 mg/d).

Fig 3

(A) TrigozimR vs. placebo; the combined effect of all TrigozimR dosages. (B) Different dosages of TrigozimR vs. placebo. *p<0.05 and **p<0.01 vs. week 0 after correction for multiple testing using Tukeys method.